NASDAQ:NEPTNeptune Wellness Solutions Stock Price, Forecast & News

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NEPT stock has increased by 160.3% and is now trading at $3.15. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neptune Wellness Solutions.

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Neptune Wellness Solutions.

Neptune Wellness Solutions Inc (NASDAQ:NEPT) released its earnings results on Wednesday, June, 10th. The biotechnology company reported ($0.21) EPS for the quarter, missing the Zacks' consensus estimate of ($0.08) by $0.13. The biotechnology company had revenue of $7.11 million for the quarter, compared to analyst estimates of $6.32 million. Neptune Wellness Solutions had a negative return on equity of 51.03% and a negative net margin of 204.83%. View Neptune Wellness Solutions' earnings history.

Neptune Wellness Solutions issued an update on its first quarter 2021 After-Hours earnings guidance on Wednesday, June, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18-22 million.

3 brokerages have issued 1-year price objectives for Neptune Wellness Solutions' stock. Their forecasts range from $3.75 to $3.75. On average, they anticipate Neptune Wellness Solutions' share price to reach $3.75 in the next year. This suggests a possible upside of 19.0% from the stock's current price. View analysts' price targets for Neptune Wellness Solutions.

Media stories about NEPT stock have trended negative recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Neptune Wellness Solutions earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Neptune Wellness Solutions.

Some companies that are related to Neptune Wellness Solutions include Odonate Therapeutics (ODT), Theravance Biopharma (TBPH), Supernus Pharmaceuticals (SUPN), I-Mab (ARQT), Constellation Pharmaceuticals (CNST), Rocket Pharmaceuticals (RCKT), DiaMedica Therapeutics (DMCAF), Athenex (ATNX), Arcus Biosciences (RCUS), Aimmune Therapeutics (AIMT), Phibro Animal Health (PAHC), Amphastar Pharmaceuticals (AMPH), Enanta Pharmaceuticals (ENTA), Akero Therapeutics (AKRO) and BioXcel Therapeutics (BTAI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Amarin (AMRN), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), Crispr Therapeutics (CRSP) and Sangamo Therapeutics (SGMO).

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NEPT stock can currently be purchased for approximately $3.15.

Neptune Wellness Solutions has a market capitalization of $334.59 million and generates $22.05 million in revenue each year. The biotechnology company earns $-45,760,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.

The official website for Neptune Wellness Solutions is www.neptunecorp.com.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]